Initiation of antihypertensive drugs to patients with confirmed COVID-19-A population-based cohort study in Sweden.

All antihypertensive medicines were initiated more frequently in COVID-19 patients. This can either be associated with hypertension caused by the COVID-19 infection, more frequent diagnosis of hypertension among people with COVID-19 since they consult health care, or residual confounding factors not adjusted for in the study.